Daily Cosmetic Research Analysis
Analyzed 21 papers and selected 3 impactful papers.
Summary
A multicenter randomized controlled trial found that a chamomile-lidocaine gel improved postoperative recovery after pediatric circumcision, reducing edema, pain, and healing time. A systematic review identified 12 key behavioral drivers of cosmetic skin whitening and highlighted the scarcity of intervention studies. National data from the BAAPS database quantified complications from cosmetic surgery tourism and the resulting NHS burden, informing harm-reduction strategies.
Research Themes
- Postoperative wound care optimization
- Behavioral determinants of cosmetic practices
- Safety and health-system burden of cosmetic surgery tourism
Selected Articles
1. Efficacy and safety of Compound Chamomile-Lidocaine Gel for postoperative wound management after pediatric circumcision: a multicenter randomized controlled trial.
In a multicenter RCT of 186 boys, adjunctive Compound Chamomile-Lidocaine Gel reduced moderate-to-severe edema at 1 week, lowered early postoperative pain, and accelerated wound healing versus saline alone. Blinded assessment and trial registration strengthen the findings, with improved cosmetic scores and satisfaction at 4 weeks.
Impact: Provides randomized evidence for a simple, topical adjunct that improves pediatric postoperative wound outcomes, potentially standardizing care pathways.
Clinical Implications: Consider adjunctive chamomile-lidocaine gel after classical pediatric circumcision to reduce edema and pain and shorten healing time; confirm generalizability in other procedures and longer follow-up.
Key Findings
- Reduced incidence of moderate-to-severe edema at 1 week with chamomile-lidocaine gel versus saline alone (blinded assessment).
- Lower maximum postoperative pain (VAS) within 2 days in the intervention group.
- Improved wound healing scores at days 3, 7, and 14 with shorter total healing time.
- Higher cosmetic scores at 4 weeks and greater patient satisfaction.
Methodological Strengths
- Multicenter randomized controlled design with blinded outcome assessors for the primary endpoint.
- Prospective trial registration (ChiCTR2400084075) with predefined outcomes.
Limitations
- Per-protocol analysis reported; intention-to-treat results not described in the abstract.
- Population limited to boys aged 8–17 undergoing classical circumcision with short-term follow-up (up to 4 weeks).
Future Directions: Evaluate efficacy across diverse surgical wounds, dose-response optimization, safety with prolonged use, and cost-effectiveness in routine care.
BACKGROUND: Circumcision is a common pediatric urological procedure for phimosis, balanitis, or cultural/religious reasons, but postoperative pain, edema, delayed healing, and infection remain key concerns. This study aimed to evaluate the safety and efficacy of Compound Chamomile-Lidocaine Gel for postoperative wound healing in children undergoing classical circumcision. METHODS: A multicenter, randomized, controlled trial was conducted in 186 boys aged 8-17 years. Participants were randomly assigned to receive postoperative wound treatment with either saline alone (control group) or saline combined with Compound Chamomile-Lidocaine Gel (intervention group). The primary outcome was the degree of local edema 1 week after surgery, assessed by blinded evaluators. Secondary outcomes included maximum pain score (Visual Analogue Scale, VAS) within 2 days postoperatively, wound healing scores (days 3, 7, 14), total wound healing time, cosmetic scores at 4 weeks, patient satisfaction, and infection rates (days 7, 14). RESULTS: In the per-protocol set (PPS), the incidence of moderate-to-severe edema was significantly lower in the intervention group than in the control group (10.59% CONCLUSIONS: Compound Chamomile-Lidocaine Gel combined with saline significantly reduces edema, alleviates pain, and shortens healing time after pediatric circumcision. These findings suggest its potential value in clinical applications. TRIAL REGISTRATION: Chinese Clinical Trial Registry (Registration No. ChiCTR2400084075); Date of Registration: 10/05/2024.
2. Why are people cosmetic skin whitening? A systematic review.
This systematic review synthesized 43 studies and identified 12 behavioral drivers of cosmetic skin whitening, with use more prevalent among women and younger adults and prevalence ranging from 2% to 74% across settings. Only one intervention study was found, underscoring a critical evidence gap for harm-reduction strategies.
Impact: Defines a comprehensive behavioral framework for a widespread cosmetic practice with documented health risks, guiding the design of theory-driven public health interventions.
Clinical Implications: Clinicians and public health practitioners should address social and psychological drivers (e.g., colorism, low risk awareness) in counseling and develop culturally tailored, theory-based interventions to reduce harmful skin whitening practices.
Key Findings
- Twelve behavioral drivers of cosmetic skin whitening were identified, including beauty ideals, self-esteem, partner attraction/marriage, dissatisfaction with skin tone, low risk awareness, social status, social norms/influence, employment motives, colorism, advertising, and fashion.
- Prevalence of cosmetic skin whitening ranged from 2% to 74% across studies and was more common among women and younger adults.
- Only one study reported an intervention aimed at raising awareness of harms, highlighting a substantial gap in intervention research.
Methodological Strengths
- Comprehensive multi-database search (five databases) without date or country restrictions.
- Synthesizes cross-disciplinary behavioral domains (psychological, social/cultural, environmental).
Limitations
- Heterogeneity across countries and study designs limits direct comparability.
- Scarcity of evaluated interventions (only one study) constrains actionable evidence.
Future Directions: Develop and rigorously test culturally tailored, theory-based interventions; incorporate measures to address colorism and social norms; evaluate policy-level actions.
BACKGROUND: Cosmetic skin whitening is a growing practice in a number of countries and long-term use has been shown to have potentially serious health risks. No reviews have documented the behavioral factors that help explain practices related to cosmetic skin whitening. METHODS: We conducted a systematic review exploring the main behavioral (psychological and cognitive, social and cultural, and environmental) factors behind the practice of cosmetic skin whitening, as well as the groups and characteristics are associated with the practice as well as what interventions have been designed to address this practice. Five databases (PubMed, Scopus, APA PsychINFO, ASSIA, and Web of Science's Preprint Citation Index) were searched using adaptations of key search terms (e.g. "skin whitening", "behavior", "risk"). Studies were not restricted by date or country. RESULTS: From 816 candidate studies, 43 studies were included in the final sample. Twelve main factors were identified: beauty; self-esteem; to attract a partner or get married; dissatisfaction with skin tone; low awareness of risks of skin whitening; to look whiter or fairer; for social status; social norms or social influence; for a job or to secure employment; colorism; the influence of advertising; and fashion. Prevalence of use ranged from 2-74%. Use was more common amongst women and younger adults but varied by country or region in terms of whether it was more commonly used by people with high or low formal education. Only one study documented an intervention designed to raise awareness of the harms of cosmetic skin whitening. CONCLUSIONS: Cosmetic skin whitening is a complex practice influenced by multiple behavioral factors. Findings should be used to inform theory-based interventions designed to reduce the prevalence of cosmetic skin whitening practices.
3. Beauty Abroad, Burden at Home: Complications and NHS Impact of Cosmetic Tourism-Insights From the BAAPS National Database.
Analysis of 198 BAAPS-reported cases shows cosmetic surgery tourism commonly leads to wound complications (dehiscence 37%, infection 28%) and often requires operative management (48%), with significant NHS costs (~£1.2–1.8M over two years) and one death. Recurrent contributory factors included inadequate aftercare, poor preoperative optimization, and premature air travel.
Impact: Provides national-level, procedure-specific complication profiles and cost estimates that can inform patient counseling, policy, and cross-border accreditation efforts.
Clinical Implications: Implement pre-travel risk counseling, mandate clear aftercare plans and complication insurance, and consider international accreditation/standards to reduce preventable harm and NHS burden.
Key Findings
- Among 198 cases, 93% were female (mean age 39), and 76% had surgery in Turkey; abdominoplasty was most common (45%).
- Frequent complications: wound dehiscence 37%, infection 28%, seroma 24%, tissue necrosis 20%.
- Nearly half (48%) required operative management under general anesthesia; 4% needed ICU; one death due to pulmonary embolism.
- Contributory factors included inadequate aftercare (21%), poor preoperative optimization (12%), and premature air travel (5%). Estimated NHS costs totaled ~£1.2–1.8M over two years.
Methodological Strengths
- National-level dataset with standardized BAAPS five-stage complication grading.
- Thematic analysis identifying recurrent contributory factors.
Limitations
- Retrospective analysis of cases reported to the BAAPS database; the total number of UK cosmetic tourists is not captured.
- Findings reflect reported cases over a two-year period and may not generalize to unreported settings.
Future Directions: Prospective national surveillance with denominator data, evaluation of accreditation and insurance models, and standardized cross-border care pathways.
BACKGROUND: Cosmetic surgery tourism has increased rapidly, with growing numbers of UK patients returning with complications requiring NHS care. Limited regulation and inconsistent perioperative standards contribute to preventable harm. OBJECTIVES: To characterise the nature, severity, and causes of complications from overseas cosmetic surgery and estimate the resulting burden on the NHS. METHODS: A national retrospective study analysed all 198 cases reported to the British Association of Aesthetic Plastic Surgeons (BAAPS) Cosmetic Tourism Complications Database between September 2022 and September 2024. Demographic, procedural, and clinical data were examined, and complications were graded using the BAAPS five-stage classification. RESULTS: Patients were predominantly female (93%) with a mean age of 39 years; 76% had surgery in Turkey. Abdominoplasty (45%) was the most common procedure, followed by breast and liposuction surgeries. Frequent complications included wound dehiscence (37%), infection (28%), seroma (24%), and tissue necrosis (20%). Nearly half (48%) required operative management under general anaesthesia, 28% minor procedures, and 4% intensive care; one death occurred from pulmonary embolism. Thematic analysis identified inadequate aftercare (21%), poor preoperative optimisation (12%), and premature air travel (5%) as recurrent contributory factors. Estimated NHS treatment costs (£5,883-£9,328 per patient) equated to £1.2-1.8 million over two years. CONCLUSIONS: Cosmetic surgery tourism poses a substantial clinical and financial challenge for the NHS. A multi-level harm-reduction strategy-encompassing patient education, complication insurance, international accreditation, and data surveillance-is essential to improve safety and reduce preventable harm.